Envestnet Asset Management’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-85,334
| Closed | -$1.29M | – | 3223 |
|
|
2019
Q4 | $1.29M | Buy |
85,334
+4,765
| +6% | +$41.1K | ﹤0.01% | 1867 |
|
|
2019
Q3 | $515K | Buy |
80,569
+17,200
| +27% | +$144K | ﹤0.01% | 2352 |
|
|
2019
Q2 | $606K | Buy |
63,369
+3,884
| +7% | +$41.8K | ﹤0.01% | 2274 |
|
|
2019
Q1 | $806K | Buy |
59,485
+18,867
| +46% | +$157K | ﹤0.01% | 2025 |
|
|
2018
Q4 | $292K | Buy |
+40,618
| New | +$444K | ﹤0.01% | 2443 |
|
|
2018
Q1 | – | Sell |
-12
| Closed | – | – | 3012 |
|
|
2017
Q4 | $0 | Sell |
12
-798
| -99% | -$21.2K | ﹤0.01% | 3033 |
|
|
2017
Q3 | $22K | Buy |
810
+39
| +5% | +$1.02K | ﹤0.01% | 2478 |
|
|
2017
Q2 | $22K | Sell |
771
-1,130
| -59% | -$34.3K | ﹤0.01% | 2584 |
|
|
2017
Q1 | $65K | Buy |
1,901
+1,124
| +145% | +$36.3K | ﹤0.01% | 2330 |
|
|
2016
Q4 | $24K | Buy |
+777
| New | +$25K | ﹤0.01% | 2632 |
|
|
2016
Q1 | – | Sell |
-1,330
| Closed | -$46K | – | 3192 |
|
|
2015
Q4 | $46K | Buy |
+1,330
| New | +$38.2K | ﹤0.01% | 2706 |
|
Envestnet Asset Management's DERM Position: Q1 2020 in Review
Envestnet Asset Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 85,334 shares — an estimated $1.29M sold.
Envestnet Asset Management first reported a position in DERM in Q4 2015 and held it in 11 quarters. The position peaked at $1.29M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Envestnet Asset Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Envestnet Asset Management sold 85,334 Dermira, Inc. shares in Q1 2020, an estimated $1.29M.
- Envestnet Asset Management first reported a position in Dermira, Inc. in Q4 2015 and held it in 11 quarters.
- Envestnet Asset Management's Dermira, Inc. position peaked at $1.29M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Envestnet Asset Management's 13F filing for Q1 2020, filed 23 Apr 2020.